In-Cyprus (press release) (subscription) (blog) |
GSK: New biotech asthma drug
In-Cyprus (press release) (subscription) (blog) GlaxoSmithKline may get a green light from European regulators as early as this week for a new biotech medicine to treat severe asthma, boosting prospects for its struggling respiratory business. A recommendation from the European Medicines Agency … |
View full post on asthma – Google News